Ying Li

Title: Ying Li - Innovator in Tyrosine Kinase Inhibitors

Introduction

Ying Li is a notable inventor based in Gansu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as tyrosine kinase inhibitors. His work is crucial in advancing medical treatments and therapies.

Latest Patents

Ying Li holds a patent for "4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors." This invention relates to specific compounds that are effective in inhibiting tyrosine kinases, which play a vital role in various cellular processes. The patent details the preparation methods for these compounds, their pharmaceutical compositions, and their potential uses in medicine.

Career Highlights

Ying Li is associated with Qilu Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in developing effective pharmaceutical compounds has positioned him as a key player in his field.

Collaborations

Ying Li has worked alongside talented colleagues such as Jingyi Wang and Chuanwen Fan. Their collaborative efforts enhance the research and development capabilities within their organization.

Conclusion

Ying Li's contributions to the field of pharmaceuticals, particularly through his patent on tyrosine kinase inhibitors, highlight his role as an influential inventor. His work continues to impact medical science and improve therapeutic options for patients.